Tag: Eli Lilly

  • Eli Lilly Could Soon See US FDA Approval for Obesity Drug

    Eli Lilly Could Soon See US FDA Approval for Obesity Drug

    Eli Lilly (LLY) could see higher highs. All as new obesity drug trial results set it up for potential US FDA approval. In fact, in recent trials, patients with Type 2 diabetes lost 15.7% of their body weight within 72 weeks, according to the company. In addition, Eli Lilly noted that “The study met both…

  • This Could be a Mega-Blockbuster for Eli Lilly

    This Could be a Mega-Blockbuster for Eli Lilly

    The obesity epidemic is still bursting at the seams. At the moment, 1.9 billion people are overweight, with more than 650 million considered obese.  In addition, by 2022, $245 billion will be spent on products and services battling the issue.  However, there may be some good news for those looking to shed extra weight. The…

  • The Top Two Vaccine Stocks to Avoid

    The Top Two Vaccine Stocks to Avoid

    There’s no such thing as a perfect trial. Fortunately, there are safeguards in place to stop trials in the event of a mishap.  We’ve seen two just this week, which could put a good deal of pressure on their stocks. Hopefully, the events won’t prevent these companies from moving forward for long. Shares of Eli…

  • President Trump Pushing these Two COVID-19 Stocks Higher

    President Trump Pushing these Two COVID-19 Stocks Higher

    Days after leaving the hospital, President Trump is urging regulators to approve emergency use authorization of Regeneron’s (REGN) and Ell Lilly’s (LLY) treatments. He specifically noted that the REGN cocktail was key to his successful treatment. “We have hundreds of thousands of doses that are just about ready,” Trump said. “I have emergency use authorization all…